Iraqi Board Clinical Pharmacy
Iraqi Board of Clinical Pharmacy Comprehensive Written Exam (FIBMS)
Oncology Critical Care SafetyEnglish
Exam overviewPractice session
A 52-year-old female with breast cancer is scheduled for adjuvant chemotherapy with doxorubicin. What is the established cumulative lifetime dose limit for doxorubicin to prevent irreversible, dose-dependent cardiomyopathy and congestive heart failure, and which cardioprotective agent can be used when exceeding this threshold?
Loading your practice session…